Cash flows from operating activities: | |
Net loss | |
Adjustments to reconcile net loss to net cash used in operating activities: | |
Non-cash restructuring charges | |
Depreciation and amortization | 40.86M |
Stock-based compensation | 68.6M |
Loss on debt redemption | |
Changes in operating assets and liabilities: | |
Accounts receivable | -6.71M |
Prepaid expenses and other assets | -13.32M |
Accounts payable | 25.68M |
Accrued and other current liabilities | 15.02M |
Deferred revenue | |
Net cash (used in) provided by operating activities | |
Cash flows from investing activities: | |
Capital expenditures | -104.41M |
Sales and maturities of marketable securities | 77.82M |
Net cash (used in) provided by investing activities | |
Cash flows from financing activities: | |
Proceeds from issuance of common stock under stock plans | |
Redemption of convertible notes | |
Net cash provided by (used in) financing activities | |
Net decrease in cash and cash equivalents | 58.66M |
Cash and cash equivalents at beginning of period | 521.44M |
Cash and cash equivalents at end of period | 580.1M |